{
  "symbol": "GEHC",
  "name": "GE HealthCare",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "2023-01-04",
  "headquarters": "Chicago, Illinois",
  "founded": "1994",
  "market_cap": 34355.109888,
  "pe_ratio": 15.762604,
  "forward_pe": 16.066381,
  "eps": 4.76,
  "revenue": 19798.99904,
  "profit_margin": 0.11026,
  "debt_to_equity": 97.515,
  "return_on_equity": 0.26444,
  "dividend_yield": 0.19,
  "current_price": 75.02999877929688,
  "year_high": 94.75053960110962,
  "year_low": 57.61992111821929,
  "price_change_1d": -0.22606140404808384,
  "price_change_1w": -1.2113208767766848,
  "price_change_1m": 4.863725477442264,
  "description": "GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certai",
  "website": "https://www.gehealthcare.com",
  "employees": 53000,
  "exchange": "NMS",
  "currency": "USD",
  "analyst_target_price": 87.353,
  "recommendation": 1.66667,
  "number_of_analysts": 20,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 110.0,
    "target_low": 73.0,
    "target_mean": 87.353,
    "target_median": 85.5
  },
  "last_updated": "2025-07-09T11:22:21.904244",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}